PARVOVIRUS B19 INFECTION REACTIVATION

PARVOVIRUS B19 INFECTION REACTIVATION was reported 32 times

PARVOVIRUS B19 INFECTION REACTIVATION is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MYCOPHENILIC ACID 11 0.0005
1 SIROLIMUS 7 0.0005
2 CEFOTAXIME INJECTION 2 0.0005
3 TECLISTAMAB-CQYV 1 0.0004
4 (DAUNORUBICIN AND CYTARABINE) LIPOSOME 1 0.0004
5 MYCOPHENOLIC ACID 11 0.0003
6 HUMAN IMMUNOGLOBULIN G 4 0.0002
7 GANCICLOVIR SODIUM 2 0.0002
8 EVEROLIMUS TABLETS 3 0.0002
9 TACROLIMUS OINTMENT 0.1% 18 0.0001
10 TACROLIMUS EXTENDED-RELEASE CAPSULES 18 0.0001
11 TACROLIMUS 19 0.0001
12 VALGANCICLOVIR 2 0.0001
13 CYCLOSPORINE 8 0.0001
14 BUSULFAN 1 0.0001
15 EVEROLIMUS 3 0.0001
16 ALEMTUZUMAB 1 0.0001
17 MYCOPHENOLATE MOFETIL 7 0.0001
18 FLUDARABINE PHOSPHATE 2 0.0001
19 RITUXIMAB 10 0.0000
20 METRONIDAZOLE TOPICAL 2 0.0000
21 MELPHALAN HYDROCHLORIDE 1 0.0000
22 VANCOMYCIN 2 0.0000
23 METRONIDAZOLE 2 0.0000
24 RUXOLITINIB 2 0.0000
25 METHYLPREDNISOLONE SODIUM SUCCINATE 1 0.0000
26 PREDNISONE 7 0.0000
27 SULFAMETHOXAZOLE AND TRIMETHOPRIM 1 0.0000
28 MYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 0.0000
29 METHYLPREDNISOLONE 1 0.0000
30 CYCLOPHOSPHAMIDE FOR INJECTION 1 0.0000
31 CYCLOPHOSPHAMIDE 1 0.0000
32 PREDNISOLONE ORAL SOLUTION 1 0.0000
33 METHOTREXATE SODIUM 2 0.0000